Free Trial

Clearside Biomedical (CLSD) Competitors

Clearside Biomedical logo
$1.01
-0.01 (-0.98%)
(As of 11/1/2024 ET)

CLSD vs. MRKR, EYEN, DSGN, ACB, URGN, PRQR, ACIU, QURE, BTMD, and GNFT

Should you be buying Clearside Biomedical stock or one of its competitors? The main competitors of Clearside Biomedical include Marker Therapeutics (MRKR), Eyenovia (EYEN), Design Therapeutics (DSGN), Aurora Cannabis (ACB), UroGen Pharma (URGN), ProQR Therapeutics (PRQR), AC Immune (ACIU), uniQure (QURE), biote (BTMD), and Genfit (GNFT). These companies are all part of the "pharmaceutical products" industry.

Clearside Biomedical vs.

Clearside Biomedical (NASDAQ:CLSD) and Marker Therapeutics (NASDAQ:MRKR) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, community ranking, risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations and earnings.

Clearside Biomedical presently has a consensus price target of $5.17, suggesting a potential upside of 411.55%. Marker Therapeutics has a consensus price target of $19.00, suggesting a potential upside of 419.13%. Given Marker Therapeutics' higher probable upside, analysts plainly believe Marker Therapeutics is more favorable than Clearside Biomedical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Clearside Biomedical
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
3.00
Marker Therapeutics
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

18.8% of Clearside Biomedical shares are held by institutional investors. Comparatively, 22.4% of Marker Therapeutics shares are held by institutional investors. 9.2% of Clearside Biomedical shares are held by company insiders. Comparatively, 17.4% of Marker Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Clearside Biomedical had 3 more articles in the media than Marker Therapeutics. MarketBeat recorded 3 mentions for Clearside Biomedical and 0 mentions for Marker Therapeutics. Clearside Biomedical's average media sentiment score of 0.49 beat Marker Therapeutics' score of 0.00 indicating that Clearside Biomedical is being referred to more favorably in the media.

Company Overall Sentiment
Clearside Biomedical Neutral
Marker Therapeutics Neutral

Clearside Biomedical has a beta of 2.35, suggesting that its stock price is 135% more volatile than the S&P 500. Comparatively, Marker Therapeutics has a beta of 1.48, suggesting that its stock price is 48% more volatile than the S&P 500.

Marker Therapeutics has lower revenue, but higher earnings than Clearside Biomedical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clearside Biomedical$7.52M10.03-$32.49M-$0.50-2.02
Marker Therapeutics$3.31M9.86-$8.24MN/AN/A

Clearside Biomedical received 293 more outperform votes than Marker Therapeutics when rated by MarketBeat users. Likewise, 67.59% of users gave Clearside Biomedical an outperform vote while only 63.72% of users gave Marker Therapeutics an outperform vote.

CompanyUnderperformOutperform
Clearside BiomedicalOutperform Votes
365
67.59%
Underperform Votes
175
32.41%
Marker TherapeuticsOutperform Votes
72
63.72%
Underperform Votes
41
36.28%

Marker Therapeutics has a net margin of -278.27% compared to Clearside Biomedical's net margin of -444.66%. Clearside Biomedical's return on equity of 0.00% beat Marker Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Clearside Biomedical-444.66% N/A -93.90%
Marker Therapeutics -278.27%-78.91%-66.10%

Summary

Clearside Biomedical beats Marker Therapeutics on 9 of the 15 factors compared between the two stocks.

Get Clearside Biomedical News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLSD and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CLSD vs. The Competition

MetricClearside BiomedicalPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$75.48M$7.42B$5.50B$8.53B
Dividend YieldN/A7.96%5.13%4.14%
P/E Ratio-2.0210.05116.1015.23
Price / Sales10.03400.761,496.2597.74
Price / CashN/A47.3939.7434.10
Price / Book-4.045.594.775.07
Net Income-$32.49M$153.56M$119.06M$225.46M
7 Day Performance-8.18%0.13%0.80%0.37%
1 Month Performance-24.63%15.23%5.65%3.57%
1 Year Performance26.25%41.14%36.75%29.43%

Clearside Biomedical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CLSD
Clearside Biomedical
2.1503 of 5 stars
$1.01
-1.0%
$5.17
+411.6%
+32.4%$75.48M$7.52M-2.0230Gap Down
MRKR
Marker Therapeutics
3.5627 of 5 stars
$4.05
-0.5%
$19.00
+369.1%
+28.9%$36.14M$3.31M0.0060
EYEN
Eyenovia
2.9442 of 5 stars
$0.49
-7.5%
$12.00
+2,347.0%
-63.9%$26.42M$31,405.00-0.6140
DSGN
Design Therapeutics
1.4232 of 5 stars
$5.24
-5.9%
$7.00
+33.6%
+157.4%$296.69MN/A-5.8240Positive News
ACB
Aurora Cannabis
0.7297 of 5 stars
$5.42
-4.6%
N/A+22.3%$295.64M$278.98M-7.741,073Upcoming Earnings
URGN
UroGen Pharma
3.98 of 5 stars
$12.26
-5.8%
$48.38
+294.6%
+7.4%$287.55M$85.01M-3.74200Upcoming Earnings
PRQR
ProQR Therapeutics
3.0395 of 5 stars
$3.50
-4.4%
$5.88
+67.9%
+221.6%$285.88M$15.41M-12.07180Upcoming Earnings
Analyst Upgrade
ACIU
AC Immune
3.1595 of 5 stars
$2.84
-4.4%
$12.00
+322.5%
+1.7%$280.87M$15.49M-3.94140Short Interest ↓
News Coverage
Positive News
QURE
uniQure
2.2854 of 5 stars
$5.72
-9.2%
$19.50
+240.9%
+1.7%$278.56M$15.84M-0.96500Upcoming Earnings
BTMD
biote
3.9719 of 5 stars
$5.10
-0.4%
$8.39
+64.5%
-1.9%$276.51M$187.23M30.00194Short Interest ↓
GNFT
Genfit
1.5162 of 5 stars
$5.53
-5.5%
$13.00
+135.1%
+94.8%$276.16M$76.06M0.00120Short Interest ↑
News Coverage

Related Companies and Tools


This page (NASDAQ:CLSD) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners